How head, neck & throat cancer is misdiagnosed or diagnosed late

"Head and neck cancer" covers a group of mostly squamous-cell cancers of the voice box (larynx), throat (pharynx), mouth and tongue (oral cavity), and related sites. The Irish Cancer Society reports that over 760 people are diagnosed with mouth, head and neck cancers in Ireland each year, drawing on National Cancer Registry data [1]. National Cancer Registry figures show the larynx is the single most common site, that these cancers are more common in men, and that the age at diagnosis has been falling [2], which matters because a younger non-smoker is exactly the kind of patient whose symptoms are more likely to be assumed harmless.

Unlike some cancers that are missed through a breakdown in test follow-up, head and neck cancers are usually missed at the first clinical encounter. The early symptoms are common, vague and easy to attribute to something minor. A typical pattern looks like this:

1. A symptom appears: a hoarse voice, a lump in the neck, a mouth ulcer that will not heal, or one-sided ear pain with nothing wrong in the ear.
2. The patient is reassured: "it's reflux", "it's a virus", "it's a denture sore". They may be given antibiotics, steroids or lozenges.
3. Weeks or months pass. The symptom persists or worsens, or a new one appears.
4. The cancer is finally diagnosed, often at an advanced stage that needs far more aggressive treatment.

The legal question is not whether the cancer was visible in hindsight. It is whether a reasonably competent practitioner, faced with the same symptoms, should have recognised the warning signs and referred the patient urgently for investigation. Where they should have, and did not, a claim may follow.

Common ways the diagnosis is missed

In our experience of delayed head and neck cancer claims, the same misattributions come up again and again. Recognising your own experience here does not prove negligence on its own, but it is often the starting point.

• Persistent hoarseness blamed on reflux or laryngitis. A hoarse voice that does not settle after three weeks is a classic early sign of laryngeal cancer, yet it is routinely attributed to acid reflux, a "smoker's throat", or recurrent laryngitis without onward referral.
• A neck lump treated as an infection. An unexplained, persistent lump in the neck of an adult can reflect spread to a lymph node. Assuming it is a reactive or infectious gland, without imaging or ENT assessment, is a frequent failure point.
• A non-healing mouth or throat ulcer dismissed as benign. A mouth ulcer or a red or white patch that does not heal within three weeks, especially in someone who smokes or drinks, can be an early oral cancer. Because patients often present to a dentist first, the dental route matters as much as the GP route.
• One-sided ear pain with a normal ear. Referred ear pain (otalgia) without an ear cause can signal a throat tumour, and is easily overlooked.
• Warning signs of nasopharyngeal cancer. One-sided nasal blockage with blood-stained discharge, or one-sided hearing loss, can point to a nasopharyngeal tumour and warrant specialist review.
• Risk factors not acted upon. Smoking, alcohol, and HPV raise the index of suspicion that should accompany these symptoms. HPV-related throat cancer (oropharyngeal cancer) is rising and tends to affect younger, often non-smoking patients, whose symptoms are more easily assumed to be harmless. That mismatch between the patient profile and the diagnosis is itself a recognised source of delay.

The symptoms above share one feature that matters legally: persistence. A single episode of hoarseness or one mouth ulcer is rarely suspicious. The same symptom that does not resolve, and is not explained, is what should prompt urgent referral. The table below sets out the red-flag symptoms most often missed in head and neck cancer and the persistence that should trigger an urgent ENT referral. These reflect clinical red flags used in practice, not an Irish statutory deadline.

There is an Irish dimension worth understanding. The National Cancer Control Programme operates structured, rapid-access GP referral pathways for several cancers, namely breast, prostate, lung, colorectal and melanoma [3], but there is no equivalent national rapid-access referral programme dedicated to head and neck cancer. In practice, that places more weight on the individual clinician's judgement to recognise red-flag symptoms and refer urgently. It does not lower the standard of care. If anything, it makes the failure to refer a suspicious, persistent symptom harder to defend.

Where the problem is specifically a missed referral or an ignored result rather than the symptom assessment itself, our guides to failure to refer and test results that were not followed up explain how those failures are assessed.

Proving negligence: breach of duty and causation

The standard of care: the Dunne test

The standard for medical negligence in Ireland comes from Dunne v National Maternity Hospital [1989] IR 91, reaffirmed by the Supreme Court in Morrissey v HSE [2020] IESC 6 [4]. A practitioner is negligent only where they have failed to a degree that no practitioner of equal status and skill, acting with ordinary care, would have failed. Missing the cancer is not enough on its own. The question is whether a reasonably competent GP or dentist, presented with three weeks of unexplained hoarseness or a non-healing oral ulcer, would have recognised the red flag and made an urgent referral. Our guide to breach of duty explains how this is established with independent expert evidence.

Causation: the harder battleground

Causation must be proven on the balance of probabilities, meaning it is more likely than not the breach caused the harm. The burden rests on the claimant, and in delayed-diagnosis cancer cases this is usually the hardest part. The defence will often argue that the cancer's biology meant the outcome would have been the same whenever it was found. This is where many genuine claims are won or lost.

A typical analysis in a hoarseness case runs like this. The expert evidence first establishes the breach: that the GP should have referred the patient for ENT assessment once hoarseness persisted beyond three weeks without an obvious cause. It then addresses causation: what stage the laryngeal cancer would probably have been at the time of the missed referral, what treatment that earlier stage would have allowed (often radiotherapy or limited surgery with the voice preserved), and how that compares with the advanced-stage treatment the patient actually needed. If the evidence shows that earlier referral would, on the balance of probabilities, have meant a materially better outcome or a less destructive treatment, causation can be established. The strength of that evidence, gathered from consultant head and neck surgeons, histopathologists and oncologists, is what decides these claims.

Where the first clinician was a dentist, not a GP

Head and neck cancer is unusual in that the first professional to see the warning sign is often a dentist rather than a GP. Mouth ulcers, red or white patches, and lumps inside the mouth frequently present at a routine dental check first. A dentist is expected to recognise an oral lesion that does not heal and to refer it for specialist assessment, just as a GP is expected to act on persistent hoarseness or a neck lump. The standard of care is measured against a reasonably competent practitioner of the same discipline, so the breach analysis for a dentist is judged by dental standards and the analysis for a GP by general-practice standards. Either route can found a claim where a persistent, unexplained red flag was reassured rather than referred.

Loss of chance: did the delay reduce your survival or treatment options?

Irish law has recognised that the lost chance of a better outcome can ground a claim. In Philp v Ryan [2004] IESC 105 [6] the Supreme Court awarded a delayed-diagnosis cancer patient damages for the lost opportunity the delay caused, including the distress of learning his prostate cancer might have been treated earlier. The precise scope of the doctrine in Ireland — in particular whether a lost chance below 50% is independently compensable for the physical outcome itself — remains unsettled, so it is best treated as a developing rather than a fixed principle. Because the doctrine applies across all cancer claims, we explain it in full in our guide to loss of chance. What is distinctive about head and neck cancer is what the lost chance actually consists of.

So the "lost chance" here is not only a percentage of survival. It is the lost chance of keeping an intelligible voice, of eating normally, and of avoiding a permanent breathing stoma and the visible effects of radical neck surgery. For people whose work depends on their voice (teachers, carers, sales and customer-facing roles, performers), that loss is life-changing in a way the figures alone do not capture.

The concrete measure of the harm is usually the stage shift: how far the cancer progressed during the delay. A tumour that could have been treated at an early, organ-preserving stage and was instead caught late, needing a laryngectomy and neck dissection, is the clearest illustration of a lost chance. Where a late diagnosis has shortened life expectancy, our guide to cancer misdiagnosis claims and the wider cluster cover how that is approached.

Why stage matters so much is visible in the Irish survival data. The National Cancer Registry notes that head and neck cancer is one of the cancers where late stage IV presentation remains common, with poorer outcomes, and that overall five-year survival for these cancers rose from 46 percent to 54 percent across the periods 1994 to 1999 and 2006 to 2011 [2]. A 20-year study of more than 10,000 Irish patients, published in the European Archives of Oto-Rhino-Laryngology, found five-year survival varies sharply by where the cancer is, which is why a delay that allows spread changes the outlook so much [9].

Compensation: what a claim may include

Compensation in Irish injury claims falls into two parts: general damages for pain, suffering and loss of amenity, and special damages for financial losses you can document. Our guide to general and special damages explains the distinction in detail.

In a head and neck cancer claim, these commonly include:

To show what a real Irish case can look like, though not what yours will be worth, in one High Court case (reported as SO'C v HSE), a woman who repeatedly attended her GP with a persistent sore throat and the sensation of something in her throat was not diagnosed until a 5cm tumour below her voice box was found, leaving her needing tube feeding. Her action settled for €700,000, without any admission of liability [7]. Settlements without admission of liability are common in Irish medical negligence litigation. For how amounts are built and what evidence drives them, see our wider cancer misdiagnosis guidance.

Time limits and date of knowledge

For head and neck cancer, the date of knowledge is often the day a consultant explains that an advanced tumour had been developing for some time while earlier symptoms went uninvestigated. Because hoarseness and similar symptoms come on gradually and patients are repeatedly reassured, the point at which you "ought reasonably" to have known can be genuinely arguable, which is why claiming early, or at least taking advice early, matters. Our guide to the date of knowledge and the Statute of Limitations (Amendment) Act 1991 [8] explain the rules in full.

Two further points are specific to medical claims. First, separate rules can extend time for children and for people who lack capacity. Second, unlike road traffic or workplace claims, clinical negligence claims do not go through the Injuries Resolution Board (formerly PIAB). They are exempt and proceed directly through the courts [10]. Because the date of knowledge is fact-sensitive and the deadline is strict, it is best to take advice as soon as you suspect a delay.

Frequently asked questions

References

1. Irish Cancer Society: Mouth, head and neck cancer (Accessed June 2026) [1]
2. National Cancer Registry Ireland: Cancer Trends: Head & Neck Cancer (Accessed June 2026) [2]
3. HSE / National Cancer Control Programme: Urgent cancer referrals (Accessed June 2026) [3]
4. Morrissey v Health Service Executive [2020] IESC 6, BAILII (Accessed June 2026) [4]
5. Crumlish v HSE [2024] IECA 244, Court of Appeal (reported in The Irish Times, Accessed June 2026) [5]
6. Philp v Ryan [2004] IESC 105, BAILII (Accessed June 2026) [6]
7. The Irish Times: report of SO'C v HSE settlement (Accessed June 2026) [7]
8. Statute of Limitations (Amendment) Act 1991, Irish Statute Book (Accessed June 2026) [8]
9. Sexton et al., The changing face of Irish head and neck cancer epidemiology: 20 years of data, European Archives of Oto-Rhino-Laryngology (2021) (Accessed June 2026) [9]
10. Citizens Information: Injuries Resolution Board (medical negligence exemption) (Accessed June 2026) [10]
11. Judicial Council of Ireland: Personal Injuries Guidelines 2021 (Accessed June 2026) [11]

External links are provided for verification of the legal and statistical points on this page and open on third-party websites. They are not endorsements. Law and statistics stated as at June 2026.